학술논문

Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II study
Document Type
Article
Source
In: Haematologica. (Haematologica, April 2024, 109(4):1194-1205)
Subject
Language
English
ISSN
15928721
03906078